Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (390) 390
Publication (6) 6
Patent (5) 5
Book / eBook (2) 2
Web Resource (2) 2
Book Chapter (1) 1
Book Review (1) 1
Journal / eJournal (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (197) 197
life sciences & biomedicine (189) 189
humans (166) 166
female (119) 119
male (100) 100
risk factors (85) 85
middle aged (80) 80
cardiovascular system & cardiology (76) 76
adult (75) 75
aged (62) 62
cardiac & cardiovascular systems (62) 62
cardiovascular disease (56) 56
hypertension (56) 56
abridged index medicus (52) 52
cardiovascular diseases (52) 52
medicine, general & internal (51) 51
general & internal medicine (43) 43
blood pressure (42) 42
epidemiology (37) 37
mortality (37) 37
peripheral vascular disease (37) 37
prospective studies (36) 36
pregnancy (34) 34
biological and medical sciences (33) 33
cardiovascular diseases - epidemiology (33) 33
diabetes (31) 31
medical sciences (31) 31
research (31) 31
colombia (30) 30
health aspects (30) 30
analysis (26) 26
clinical medicine (26) 26
klinisk medicin (26) 26
health risk assessment (25) 25
cardiovascular diseases - prevention & control (24) 24
developing countries (24) 24
global health (23) 23
stroke (23) 23
medicine (22) 22
metabolic syndrome (22) 22
prevalence (22) 22
medicin och hälsovetenskap (21) 21
prevention (21) 21
public, environmental & occupational health (21) 21
cardiovascular (20) 20
diabetes mellitus (20) 20
studies (20) 20
adolescent (19) 19
cardiovascular diseases - mortality (19) 19
income (19) 19
cardiology. vascular system (18) 18
endocrinology & metabolism (18) 18
hypertension - epidemiology (18) 18
case-control studies (17) 17
colombia - epidemiology (17) 17
double-blind method (17) 17
socioeconomic factors (17) 17
cross-sectional studies (16) 16
diet (16) 16
internal medicine (16) 16
kardiologi (16) 16
myocardial infarction (16) 16
obesity (16) 16
public health (16) 16
cardiac and cardiovascular systems (15) 15
preeclampsia (15) 15
cardiovascular diseases - etiology (14) 14
cholesterol (14) 14
cohort studies (14) 14
health risks (14) 14
heart diseases (14) 14
insulin resistance (14) 14
blood and lymphatic vessels (13) 13
body mass index (13) 13
care and treatment (13) 13
cerebral infarction (13) 13
clinical trials (13) 13
developed countries (13) 13
exercise (13) 13
latin america - epidemiology (13) 13
rural areas (13) 13
inflammation (12) 12
low income groups (12) 12
medical research (12) 12
nitric oxide (12) 12
nutrition (12) 12
treatment outcome (12) 12
type 2 diabetes (12) 12
arterial hypertension. arterial hypotension (11) 11
canada (11) 11
child (11) 11
endothelium (11) 11
health care (11) 11
hypertension - drug therapy (11) 11
india (11) 11
risk (11) 11
risk analysis (11) 11
rural population (11) 11
urban population (11) 11
antihypertensive agents - therapeutic use (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension
by Olsen, Michael H, DMSc and Angell, Sonia Y, MD and Asma, Samira, DDS and Boutouyrie, Pierre, Prof and Burger, Dylan, PhD and Chirinos, Julio A, PhD and Damasceno, Albertino, PhD and Delles, Christian, Prof and Gimenez-Roqueplo, Anne-Paule, Prof and Hering, Dagmara, PhD and López-Jaramillo, Patricio, Prof and Martinez, Fernando, PhD and Perkovic, Vlado, Prof and Rietzschel, Ernst R, PhD and Schillaci, Giuseppe, MD and Schutte, Aletta E, Prof and Scuteri, Angelo, PhD and Sharman, James E, PhD and Wachtell, Kristian, DMSc and Wang, Ji Guang, Prof
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 388, Issue 10060, pp. 2665 - 2712
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Blood Pressure | Global Burden of Disease | Guidelines as Topic | Global Health | Humans | Risk Factors | Hypertension - prevention & control | Hypertension - drug therapy | Hypertension - diagnosis | Hypertension | Prevention | Health aspects | Health care | Disease prevention | Lifestyles | Health risk assessment | Cardiology | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
by Yusuf, Salim and Bosch, Jackie and Dagenais, Gilles and Zhu, Jun and Xavier, Denis and Liu, Lisheng and Pais, Prem and López-Jaramillo, Patricio and Leiter, Lawrence A and Dans, Antonio and Avezum, Alvaro and Piegas, Leopoldo S and Parkhomenko, Alexander and Keltai, Matyas and Keltai, Katalin and Sliwa, Karen and Peters, Ron J.G and Held, Claes and Chazova, Irina and Yusoff, Khalid and Lewis, Basil S and Jansky, Petr and Khunti, Kamlesh and Toff, William D and Reid, Christopher M and Varigos, John and Sanchez-Vallejo, Gregorio and McKelvie, Robert and Pogue, Janice and Jung, Hyejung and Gao, Peggy and Diaz, Rafael and Lonn, Eva and HOPE-3 Investigators
The New England journal of medicine, ISSN 0028-4793, 05/2016, Volume 374, Issue 21, pp. 2021 - 2031
no | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Cardiovascular Diseases - ethnology | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Rosuvastatin Calcium - adverse effects | Male | Hypercholesterolemia - drug therapy | Rosuvastatin Calcium - administration & dosage | Medication Adherence | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Care and treatment | Usage | Clinical trials | Rosuvastatin | Dosage and administration | Cardiovascular diseases | Risk factors | Cholesterol | Hypertension | Myocardial infarction | Cerebral infarction | C-reactive protein | Diabetes mellitus | Cardiovascular disease | Lipids | Inflammation | Low density lipoprotein | Disease prevention | Surgery | Blood pressure | Health risk assessment | Drug therapy | Heart diseases | Statins | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
by Yusuf, Salim and Lonn, Eva and Pais, Prem and Bosch, Jackie and López-Jaramillo, Patricio and Zhu, Jun and Xavier, Denis and Avezum, Alvaro and Leiter, Lawrence A and Piegas, Leopoldo S and Parkhomenko, Alexander and Keltai, Matyas and Keltai, Katalin and Sliwa, Karen and Chazova, Irina and Peters, Ron J.G and Held, Claes and Yusoff, Khalid and Lewis, Basil S and Jansky, Petr and Khunti, Kamlesh and Toff, William D and Reid, Christopher M and Varigos, John and Accini, Jose L and McKelvie, Robert and Pogue, Janice and Jung, Hyejung and Liu, Lisheng and Diaz, Rafael and Dans, Antonio and Dagenais, Gilles and HOPE-3 Investigators
The New England journal of medicine, ISSN 0028-4793, 05/2016, Volume 374, Issue 21, pp. 2032 - 2043
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Rosuvastatin Calcium - adverse effects | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Hydrochlorothiazide - administration & dosage | Rosuvastatin Calcium - administration & dosage | Antihypertensive Agents - adverse effects | Medication Adherence | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Benzimidazoles - administration & dosage | Tetrazoles - administration & dosage | Cardiovascular Diseases - epidemiology | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Care and treatment | Usage | Clinical trials | Rosuvastatin | Dosage and administration | Cardiovascular diseases | Risk factors | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Antihypertensives | Cardiovascular disease | Lipids | Hydrochlorothiazide | Low density lipoprotein | Cholesterol | Disease prevention | Blood pressure | Health risk assessment | Drug therapy | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease
by Lonn, Eva M and Bosch, Jackie and López-Jaramillo, Patricio and Zhu, Jun and Liu, Lisheng and Pais, Prem and Diaz, Rafael and Xavier, Denis and Sliwa, Karen and Dans, Antonio and Avezum, Alvaro and Piegas, Leopoldo S and Keltai, Katalin and Keltai, Matyas and Chazova, Irina and Peters, Ron J.G and Held, Claes and Yusoff, Khalid and Lewis, Basil S and Jansky, Petr and Parkhomenko, Alexander and Khunti, Kamlesh and Toff, William D and Reid, Christopher M and Varigos, John and Leiter, Lawrence A and Molina, Dora I and McKelvie, Robert and Pogue, Janice and Wilkinson, Joanne and Jung, Hyejung and Dagenais, Gilles and Yusuf, Salim and HOPE-3 Investigators
The New England journal of medicine, ISSN 0028-4793, 05/2016, Volume 374, Issue 21, pp. 2009 - 2020
no | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Blood Pressure | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Hydrochlorothiazide - administration & dosage | Hypotension - chemically induced | Antihypertensive Agents - adverse effects | Incidence | Benzimidazoles - administration & dosage | Tetrazoles - administration & dosage | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Aged | Drug Therapy, Combination | Care and treatment | Usage | Candesartan | Clinical trials | Dosage and administration | Cardiovascular diseases | Risk factors | Hypertension | Myocardial infarction | Cerebral infarction | Stroke | Antihypertensives | Cardiovascular disease | Hydrochlorothiazide | Cholesterol | Blood pressure | Health risk assessment | Drug therapy | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights